/QSI
QSI Stock - Quantum-Si incorporated
Healthcare|BiotechnologyNASDAQ
$1.27+4.10%
+$0.05 (+4.10%) • Dec 19
50
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.18
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+57.5%upside
Target: $2.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for QSI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.26 – $1.28
TARGET (TP)$2.00
STOP LOSS$1.17
RISK/REWARD1:7.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.99
52W High$5.77
52W Low$0.95
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.06M | $1.08M | N/A | N/A | N/A |
| Gross Profit | $1.60M | $488,000 | N/A | N/A | N/A |
| Gross Margin | 52.3% | 45.1% | N/A | N/A | N/A |
| Operating Income | $-108,576,000 | $-111,171,000 | $-123,841,000 | $-96,908,000 | $-36,691,000 |
| Net Income | $-101,007,000 | $-95,960,000 | $-132,442,000 | $-94,989,000 | $-36,612,000 |
| Net Margin | -3303.0% | -8868.8% | N/A | N/A | N/A |
| EPS | $-0.71 | $-0.68 | $-0.95 | $-1.19 | $-6.81 |
Company Overview
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
67%
Hold / Neutral
1
33%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
2 Bullish1 Neutral/Bearish
Price Targets
$3
Average Target
↑ 129.7% Upside
Now
$2
Low
$3
Average
$4
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| February 7th 2025 | Alliance Global Partners | Initiation | Buy | $3.75 |
| December 8th 2023 | H.C. Wainwright | Initiation | Buy | $3 |
| September 25th 2023 | Canaccord Genuity | Downgrade | Hold | $2← $3.5 |
Earnings History & Surprises
QSIBeat Rate
65%
Last 17 quarters
Avg Surprise
+5.4%
EPS vs Estimate
Beats / Misses
11/3
3 met exactly
Latest EPS
$-0.17
Q4 2025
EPS Surprise History
Q1 24
0.0%
$-0.16vs$-0.16
Q2 24
+39.1%
$-0.14vs$-0.23
Q3 24
+23.8%
$-0.16vs$-0.21
Q4 24
+14.3%
$-0.18vs$-0.21
Q1 25
0.0%
$-0.18vs$-0.18
Q2 25
+35.3%
$-0.11vs$-0.17
Q3 25
0.0%
$-0.16vs$-0.16
Q4 25
-41.7%
$-0.17vs$-0.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q1 2026 | Mar 2, 2026 | $-0.14 | — | — | — |
Q4 2025 | Nov 5, 2025 | $-0.12 | $-0.17 | -41.7% | ✗ MISS |
Q3 2025 | Aug 5, 2025 | $-0.16 | $-0.16 | 0.0% | = MET |
Q2 2025 | May 15, 2025 | $-0.17 | $-0.11 | +35.3% | ✓ BEAT |
Q1 2025 | Mar 3, 2025 | $-0.18 | $-0.18 | 0.0% | = MET |
Q4 2024 | Nov 12, 2024 | $-0.21 | $-0.18 | +14.3% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $-0.21 | $-0.16 | +23.8% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $-0.23 | $-0.14 | +39.1% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | $-0.16 | $-0.16 | 0.0% | = MET |
Q4 2023 | Nov 9, 2023 | $-0.19 | $-0.15 | +21.1% | ✓ BEAT |
Q3 2023 | Aug 7, 2023 | $-0.20 | $-0.18 | +10.0% | ✓ BEAT |
Q2 2023 | May 11, 2023 | $-0.19 | $-0.17 | +10.5% | ✓ BEAT |
Q1 2023 | Mar 6, 2023 | $-0.20 | $-0.17 | +15.0% | ✓ BEAT |
Q4 2022 | Nov 7, 2022 | $-0.25 | $-0.23 | +8.0% | ✓ BEAT |
Q3 2022 | Aug 8, 2022 | $-0.24 | $-0.23 | +4.2% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $-0.17 | $-0.25 | -47.1% | ✗ MISS |
Q1 2022 | Feb 28, 2022 | $-0.17 | $-0.21 | -23.5% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-0.17 | $-0.13 | +23.5% | ✓ BEAT |
Q3 2021 | Aug 16, 2021 | — | $-3.05 | — | — |
Latest News
Quantum-Si shares are trading lower after the company reported worse-than-expected Q3 financial results.
📉 NegativeBenzinga•Nov 6, 2025, 05:17 PM
Quantum-Si Q3 EPS $(0.17) Misses $(0.14) Estimate, Sales $552.000K Miss $590.000K Estimate
📉 NegativeBenzinga•Nov 5, 2025, 09:09 PM
Quantum-Si Announces It May Offer And Sell Class A Stock Up To $100M
➖ NeutralBenzinga•Oct 29, 2025, 08:43 PM
Canaccord Genuity Maintains Hold on Quantum-Si, Raises Price Target to $2
➖ NeutralBenzinga•Oct 27, 2025, 11:30 AM•Also:
Quantum-Si shares are trading lower after the company announced it filed for a $300 million mixed-shelf offering. Also, the company announced it will pay a $11 million termination fee as part of its settlement and mutual release agreement with Winchester.
📉 NegativeBenzinga•Sep 29, 2025, 05:10 PM
Quantum-Si Files For Mixed Shelf Of Up To $300M
➖ NeutralBenzinga•Sep 26, 2025, 09:21 PM
On Sept 23, Quantum-Si Enters Settlement And Mutual Release Agreement With Winchester; To Pay $11M Termination Fee
📉 NegativeBenzinga•Sep 26, 2025, 08:08 PM
Frequently Asked Questions about QSI
What is QSI's current stock price?
Quantum-Si incorporated (QSI) is currently trading at $1.27 per share. The stock has moved +4.10% today.
What is the analyst price target for QSI?
The average analyst price target for QSI is $2.00, based on 1 analyst.
What sector is Quantum-Si incorporated in?
Quantum-Si incorporated operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is QSI's market cap?
Quantum-Si incorporated has a market capitalization of $0.25 billion, making it a small-cap company.
Does QSI pay dividends?
No, Quantum-Si incorporated does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADCT
ADC Therapeutics S.A.
$3.73
Mkt Cap: $0.4B
ALT
Altimmune, Inc.
$3.90
Mkt Cap: $0.3B
ANNX
Annexon, Inc.
$5.17
Mkt Cap: $0.6B
AURA
Aura Biosciences, Inc.
$5.86
Mkt Cap: $0.4B
AUTL
Autolus Therapeutics plc
$1.63
Mkt Cap: $0.4B
DBVT
DBV Technologies S.A.
$22.76
Mkt Cap: $0.5B
ENGN
enGene Holdings Inc.
$8.69
Mkt Cap: $0.4B
LBRX
LB Pharmaceuticals Inc Common Stock
$21.07
Mkt Cap: $0.5B
RCKT
Rocket Pharmaceuticals, Inc.
$3.23
Mkt Cap: $0.3B
SLDB
Solid Biosciences Inc.
$5.94
Mkt Cap: $0.5B
Explore stocks similar to QSI for comparison